Sirius Investors
1.30
4.00%Today
Market Cap
78.75M
Volume
355.87K
52W High
3.60
52W Low
0.85

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Company Information

CEO
Daniel J. O'Connell
Sector
Healthcare
Industry
Biotechnology
Employees
61

Contact Information

Address
427 Park Street
Country
US